Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

March 30, 2000

No Comments

ICAgen and Yamanouchi to develop novel CNS therapeutics

March 30, 2000

No Comments

Genzyme Transgenics expands agreement with Centocor for second monoclonal antibody

March 27, 2000

No Comments

Dyax and Human Genome Sciences enter drug discovery agreement

March 27, 2000

No Comments

Millennium extends inflammation and autoimmune alliance with Kyowa Hakko

March 24, 2000

No Comments

Corixa and Abgenix form MAb collaboration

March 24, 2000

No Comments

SkyePharma to develop formulation for Pfizer compound

March 24, 2000

No Comments

Novo Nordisk expands research agreement with DGI BioTechnologies

March 24, 2000

No Comments

Millennium and MorphoSys expand antibody development agreement

March 23, 2000

No Comments

Potent, selective c-Src TK inhibitor identified using new target-based method

March 16, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

ICAgen and Yamanouchi to develop novel CNS therapeutics

Genzyme Transgenics expands agreement with Centocor for second monoclonal antibody

Dyax and Human Genome Sciences enter drug discovery agreement

Millennium extends inflammation and autoimmune alliance with Kyowa Hakko

Corixa and Abgenix form MAb collaboration

SkyePharma to develop formulation for Pfizer compound

Novo Nordisk expands research agreement with DGI BioTechnologies

Millennium and MorphoSys expand antibody development agreement

Potent, selective c-Src TK inhibitor identified using new target-based method

Today's news in brief

Today's news in brief

Abbvie and Simcere enter a $1B T-cell engager deal

In monkeys, enhanced TB vaccine dissolves after inducing protection

New drugs with the same old resistance tricks?

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS